Literature DB >> 34718959

Overcoming transport barriers to immunotherapy.

Shann S Yu1, Jeffrey A Hubbell1, Melody A Swartz2,3.   

Abstract

Immunotherapies are designed to treat disease by modulating the activity of immune cells. Here, we consider how anatomy and microphysiology create transport barriers to immunotherapeutic delivery and retention at diseased sites, and summarize recent developments to overcome these barriers by exploiting immunobiology to engineer molecular and cellular engineering approaches. Creating impactful and practical solutions across these diseases requires the integration of the collective expertise of pathologists, clinicians, immunologists, biophysicists, immunoengineers, and more.
© 2021. Controlled Release Society.

Entities:  

Keywords:  Cellular engineering; Drug delivery; Immunoengineering; Immunotherapy; Molecular engineering; Pharmacodynamics; Pharmacokinetics

Mesh:

Year:  2021        PMID: 34718959     DOI: 10.1007/s13346-021-01084-4

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  1 in total

Review 1.  Lipid nanoparticles for mRNA delivery.

Authors:  Xucheng Hou; Tal Zaks; Robert Langer; Yizhou Dong
Journal:  Nat Rev Mater       Date:  2021-08-10       Impact factor: 66.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.